SINOVAC BIOTECH LTD Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q4 2018 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Sinovac Biotech Ltd quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q4 2018 to Q4 2023.
- Sinovac Biotech Ltd Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending December 31, 2023 was $6.22M, a 32.3% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)